Synthesis and evaluation of eight-membered cyclic pseudo-dipeptides

Peptides

Volumn 26, Issue 2, 2005, Pages 251-258

  Abell, Andrew D ^a   Brown, Karina M ^a   Coxon, James M ^a   Jones, Matthew A ^a   Miyamoto, Sigeru ^a   Neffe, Axel T ^a   Nikkel, Janna M ^a   Stuart, Blair G ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

Calpain; Cataract; Metathesis; Molecular modeling; Peptidomimetics

Indexed keywords

7 (4 FLUOROBENZENESULFONYLAMINO) 8 OXO 1,2,3,6,7,8 HEXAHYDROAZOCINE 2 CARBOXYLIC ACID METHYL ESTER; 7 (4 FLUOROBENZENESULFONYLAMINO) 8 OXOAZOCANE 2 CARBOXYLIC ACID METHYL ESTER; CALPASTATIN; CYCLOPEPTIDE; PSEUDOPEPTIDE; SJA 0617; SJA 6017; UNCLASSIFIED DRUG;

ARTICLE; DIASTEREOISOMER; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ISOMERISM; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RING CLOSING METATHESIS; SUBSTITUTION REACTION;

CALPAIN; COMPUTATIONAL BIOLOGY; DIPEPTIDES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES, CYCLIC; PROTEIN CONFORMATION;

EID: 11144233999     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.09.006     Document Type: Article

References (28)

1. S. Biswas, F. Harris, S. Dennison, J. Singh, and D.A. Phoenix Calpains: targets of cataract prevention? Trends Mol Med 10 2004 78 84
2. S. Biswas, F. Harris, J. Singh, and D.A. Phoenix The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017 Mol Cell Biochem 261 2004 169 173
3. C.J. Creighton, and A.B. Reitz Synthesis of an eight-membered cyclic pseudo-dipeptide using ring closing metathesis Org Lett 3 2001 893 895
4. D.E. Croall, and K.S. McGrody Domain structure of calpain: mapping the binding site for calpastatin Biochemistry 33 1994 13223 13230
5. I.O. Donkor A survey of calpain inhibitors Curr Med Chem 7 2000 1171 1188
6. D.P. Fairlie, J.D.A. Tyndall, R.C. Reid, A.K. Wong, G. Abbenante, and M.J. Scanlon Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing J Med Chem 43 2000 1271 1281
7. B.E. Fink, P.R. Kym, and J.A. Katzenellenbogen Design, synthesis, and conformational analysis of a proposed type I β-turn mimic J Am Chem Soc 120 1998 4334 4344
8. C. Fukiage, M. Azuma, Y. Nakamura, Y. Tamada, M. Nakamura, and T.R. Shearer SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses Biochim Biophys Acta 1361 1997 304 312
9. C. Fukiage, E. Nakajima, H. Ma, M. Azuma, and T.R. Shearer Characterization and regulation of lens-specific calpain Lp82 J Biol Chem 277 2002 20678 20685
10. S. Gil-Parrado, I. Assfalg-Machleidt, F. Florino, D. Deluca, D. Pfeiler, and N. Schaschke Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin Biol Chem 384 2003 395 402
11. R.H. Grubb, and S. Chang Recent advances in olefin metathesis and its application in organic synthesis Tetrahedron 54 1998 4413 4450
12. 2-like domain J Biol Chem 276 2001 7404 7407
13. Y. Huang, and K.K. Wang The calpain family and human diseases Trends Mol Med 7 2001 355 362
14. J. Inoue, M. Nakamura, Y. Cui, Y. Sakai, O. Sakai, and J.R. Hill Structure-activity relationship and drug profile of N-(4-fluorophenylsulfonyl)-l valyl-l-leucinal (SJA6017) as a potent calpain inhibitor J Med Chem 46 2003 868 871
15. G.D. Lin, D. Chattopadhyay, M. Maki, K.K.W. Wang, M. Carson, and L. Jin Crystal structure of calcium bound domain VI of calpain at 1.9 Å resolution and its role in enzyme assembly, regulation, and inhibitor binding Nat Struct Biol 4 1997 539 547
16. F. Mohamadi, N.G.I. Richards, W.C. Guida, R. Liskamp, M. Lipton, and C. Caufield MacroModel - an integrated software system for modeling organic and bioorganic molecules using molecular mechanics J Comp Chem 11 1990 440 467
17. 2+ switch aligns the active site of calpain Cell 108 2002 649 660
18. A. Nadin, S. Derrer, R.P. McGeary, J.M. Goodman, P.R. Raithby, and A.B. Holmes Seven-membered lactams as constraints for amide self-recognition J Am Chem Soc 117 1995 9768 9769
19. R.A. Nixon The calpains in aging and aging-related diseases Ageing Res Rev 2 2003 407 418
20. R.C. Reid, L.K. Pattenden, J.D.A. Tyndall, J.L. Martin, T. Walsh, and D.P. Fairlie Countering cooperative effects in protease inhibitors using constrained beta-strand mimicking templates in focused combinatorial libraries J Med Chem 47 2004 1641 1651
21. D. Reverter, M. Braun, C. Fernandez-Catalan, S. Strobl, H. Sorimachi, and W. Bode Flexibility analysis and structure comparison of two crystal forms of calcium-free human m-calpain Biol Chem 383 2000 1415 1422
22. D. Reverter, S. Strobl, C. Fernandez-Catalan, H. Sorimachi, K. Suzuki, and W. Bode Structural basis for possible calcium-induced activation mechanisms of calpains Biol Chem 382 2001 753 766
23. P.S. Shenkin, and D.Q. McDonald Cluster analysis of molecular conformations J Comp Chem 15 1994 899 916
24. Y. Tamada, C. Fukiage, K. Mizutani, M. Yamaguchi, Y. Nakamura, and M. Azuma Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats Curr Eye Res 22 2001 280 285
25. V.F. Thompson, S. Saldana, J. Cong, and D.E. Goll A BODIPY fluorescent microplate assay for measuring activity of calpains and other proteases Anal Biochem 279 2000 170 178
26. B. Todd, D. Moore, C.C.S. Deivanayagam, G. Lin, D. Chattopadhyay, and M. Maki A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor J Mol Biol 328 2003 131 146
27. P. Tompa, P. Buzder-Lanots, A. Tantos, A. Farkas, A. Szilagyi, and F. Banoczi Hudesc On the sequential determinants of calpain cleavage J Biol Chem 279 2004 20775 20785
28. K.K.W. Wang, R. Nath, A. Posner, K.J. Raser, M. Buroker-Kilgore, and I. Hajimohammadreza An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective Proc Natl Acad Sci USA 93 1996 6687 6692